ON DRUGS Inc

Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$1,180,776
Receivables (Non-Related)
30%
Cash & Equivalents
30%
Other Assets
21%
Property, Plant, & Equipment (net)
16%
Prepaid Expenses
3%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Liabilities in 2025 (Year End)
$275,633
Other Liabilities
88%
Payables & Accruals
12%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$369,665
$352,892
-5%
Receivables (Non-Related)
$161,632
$358,364
+122%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$1,445
$31,235
+2062%
Investments
-
-
-
Property, Plant, & Equipment (net)
$14,256
$194,302
+1263%
Other Assets
$11,824
$243,983
+1963%
Total Assets
$558,822
$1,180,776
+111%
Liabilities
2024
2025
Change
Payables & Accruals
$16,973
$32,100
+89%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$14,804
$243,533
+1545%
Total Liabilities
$31,777
$275,633
+767%
Net assets
2024
2025
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$527,045
$905,143
+72%
Net assets
2024
2025
Change
Net assets
+$527,045
+$905,143
+72%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)